TLR6 and metabolic dysfunction-associated steatotic liver disease: Therefore, we could assume that deregulated TLR6 expression and activity may potentiate the chronic low-grade pro-inflammatory state associated to obesity, in parallel with the events taking place in the liver, which eventually determine NAFLD severity.